William J. Chase is CFO & VP at AbbVie Inc. (ABBV). They have made 6 open-market trades across 2 companies since 2014, most recently 2026-07-15.
CIK 0001563572
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $4.1M since 2019, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NTLA | BUY | 2025-08-20 | 2025-08-22 | $10.03 | $2.0M | +5.0% | +55.9% | -27.4% |
| ABBV | BUY | 2019-06-26 | 2019-06-28 | $67.30 | $2.0M | -3.1% | -8.6% | +0.7% |
| ABBV | SELL | 2018-12-12 | 2018-12-14 | $90.00 | $5.4M | +5.7% | -0.4% | -6.0% |
| ABBV | SELL | 2018-02-28 | 2018-03-02 | $117.98 | $12.9M | +4.4% | -19.7% | -13.1% |
| ABBV | SELL | 2017-05-18 | 2017-05-19 | $65.35 | $2.5M | +1.8% | +8.8% | +6.6% |
| ABBV | SELL | 2016-12-02 | 2016-12-02 | $59.19 | $391K | +3.5% | +4.7% | +6.1% |
| ABBV | SELL · 10b5-1 | 2014-12-22 | 2014-12-22 | $68.00 | $578K | -11.8% | -0.8% | -0.8% |
| ABBV | SELL · 10b5-1 | 2014-03-03 | 2014-03-04 | $50.22 | $198K | -11.8% | -0.8% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.